Clinical Trials
3 trialsNCT01802814 2024-02-09
International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010
Charite University, Berlin, Germany
Phase 3 Completed
NCT01354457 2014-06-25
RIT 90YEpra
Nantes University Hospital
Phase 1/2 Unknown
NCT00941928 2014-05-22
Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)
M.D. Anderson Cancer Center
Phase 2 Terminated